Determining the right regulatory pathway for a drug product is a critical early decision that can shape the entire development strategy. While many products may appear to fit the generic model, nuances in formulation, dosage form, route of administration, or intended use can disqualify them from a traditional Abbreviated New Drug Application (ANDA). In such…